aTyr Pharma experienced a catastrophic trading session Monday as shares plummeted 83% following the announcement that its pivotal Phase 3 clinical trial failed to meet its primary endpoint. The ...
aTyr Pharma, Inc. (ATYR) Securities Litigation: The suit, Munguia v. aTyr Pharma Inc., filed in the U.S. District Court for the Southern District of California, alleges that aTyr and its top ...
SAN FRANCISCO, Nov. 26, 2025 /PRNewswire/ -- The financial and legal pressures on aTyr Pharma, Inc. (NASDAQ: ATYR) intensified earlier this month as the clinical-stage biotech company reported ...
In addition to the presentations, company management will be available to participate in one-on-one meetings with investors who are registered attendees of the RBC and Jefferies conferences. A webcast ...
So, the natural question for aTyr Pharma (NASDAQ:ATYR) shareholders is whether they should be concerned by its rate of cash ...
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class ...
SAN FRANCISCO, Nov. 25, 2025 /PRNewswire/ -- The financial and legal pressures on aTyr Pharma, Inc. (NASDAQ: ATYR) intensified earlier this month as the clinical-stage biotech company reported ...
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / - SueWallSt: Class Action Filed Against aTyr Pharma, Inc. - Contact Levi & Korsinsky A ...
) has been revised to $6.48 / share. This is a decrease of 37.13% from the prior estimate of $10.31 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $25.7 million in its third quarter. The San Diego-based company said it had a loss of 26 cents per share. The ...
Whales with a lot of money to spend have taken a noticeably bearish stance on aTyr Pharma. Looking at options history for aTyr Pharma ATYR we detected 18 trades. If we consider the specifics of each ...
aTyr Pharma, Inc. (ATYR) Securities Litigation: The suit, Munguia v. aTyr Pharma Inc., filed in the U.S. District Court for the Southern District of California, alleges that aTyr and its top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback